Collectively, our results established H2S stimulation of TRPV1 and the downstream release of SP as a key element in the transition of infection and SIRS to MODS in sepsis, and identified TRPV1 antagonist as a possible therapeutic target for the treatment of polymicrobial sepsis. Here, TRPV1 is linked to systemic inflammatory response syndrome.